Status:
COMPLETED
Safety and Efficacy Reconyl for Cough With/Without Sore Throat
Lead Sponsor:
Dexa Medica Group
Collaborating Sponsors:
Fakultas Kedokteran Universitas Indonesia
Conditions:
Cough
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
Brief Summary
This study is a prospective, randomized, double-blind and placebo-controlled study to find out if reconyl may relieve the acute cough with/without sore throat.
Detailed Description
Reconyl is a mixed extract from 4 Indonesian herbs, Vitex trifolia (Legundi), Zingiber officinale var. Amarum (Jahe Gajah), Abrus precatorius (Saga), and Phaleria macrocarpa (Mahkota Dewa), which have...
Eligibility Criteria
Inclusion
- Healthy men or women aged 18 to 60 years with cough with/without sore throat with a maximum onset of 3 days.
- Signing the informed consent.
Exclusion
- Body temperature of \> 37.3˚C and/or refuse to follow health protocol for COVID-19
- Known hypersensitivity to herbal drugs
- Pregnant or lactating women
- Have received any anti-inflammatory or cough-alleviating drugs within the past 24 hours
- Presence of vomiting or diarrhea within the past 24 hours and still ongoing at the start of study
- Severe illness, e.g. severe hypertension, any other chronic infections or diseases that may induce cough, such as: pulmonary tuberculosis, gastrointestinal reflux diseases (GERD)
Key Trial Info
Start Date :
July 23 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 3 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06510257
Start Date
July 23 2024
End Date
October 3 2024
Last Update
February 7 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Imeri Fkui
Jakarta Pusat, DKI Jakarta, Indonesia, 10430
2
Klinik Satelit Makara UI Depok
Depok, West Java, Indonesia